Modulating mTOR in aging and health

Interdisciplinary Topics in Gerontology

Volumn 40, Issue , 2014, Pages 107-127

  Johnson, Simon C ^a   Sangesland, Maya ^a   Kaeberlein, Matt ^a   Rabinovitch, Peter S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

AGING; ANIMAL; DRUG EFFECTS; HEALTH STATUS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGING; ANIMALS; HEALTH STATUS; HUMANS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84925947258     PISSN: 00741132     EISSN: 16623800     Source Type: Book Series    
DOI: 10.1159/000364974     Document Type: Article

References (49)

1. Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, Sathe GM, Faucette L, Eng WK, Johnson RK, Livi GP: Dominant missense mutations in a novel yeast protein related to mammalian phospha-tidylinositol 3-kinase and VPS34 abrogate rapamy-cin cytotoxicity. Mol Cell Biol 1993; 13:6012-6023.
2. Chiu MI, Katz H, Berlin V: RAPT1, a mammalian homolog of yeast TOR, interacts with the FKBP12/rapamycin complex. Proc Natl Acad Sci USA 1994; 91:12574-12578.
3. Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Lon-go VD: Regulation of longevity and stress resistance by Sch9 in yeast. Science 2001; 292:288-290.
4. Jia K, Chen D, Riddle DL: The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004; 131:3897-3906.
5. Johnson SC, Rabinovitch PS, Kaeberlein M: mTOR is a key modulator of ageing and age-related disease. Nature 2013; 493:338-345.
6. Kenyon CJ: The genetics of ageing. Nature 2010; 464: 504-512.
7. Huang J, Manning BD: The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Bio-chem J 2008; 412:179-190.
8. Xie X, Guan KL: The ribosome and TORC2: collaborators for cell growth. Cell 2011; 144:640-642.
9. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ: AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30:214-226.
10. Björntorp P, Carlström S, Fagerberg SE, Hermann LS, Holm AG, Scherstén B, Ostman J: Influence of phenformin and metformin on exercise-induced lactataemia in patients with diabetes mellitus. Diabe-tologia 1978; 15:95-98.
11. Jewell JL, Russell RC, Guan KL: Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 2013; 14:133-139.
12. Mercken EM, Carboneau BA, Krzysik-Walker SM, de Cabo R: Of mice and men: the benefits of caloric restriction, exercise, and mimetics. Ageing Res Rev 2012; 11:390-398.
13. Swindell WR: Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan. Ageing Res Rev 2012; 11:254-270.
14. Hansen M, Taubert S, Crawford D, Libina N, Lee SJ, Kenyon C: Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging cell 2007; 6:95-110.
15. Proud CG: mTORC1 signalling and mRNA translation. Biochem Soc Trans 2009; 37:227-231.
16. Steffen KK, MacKay VL, Kerr EO, Tsuchiya M, Hu D, Fox LA, Dang N, Johnston ED, Oakes JA, Tchao BN, Pak DN, Fields S, Kennedy BK, Kaeberlein M: Yeast life span extension by depletion of 60s ribo-somal subunits is mediated by Gcn4. Cell 2008; 133: 292-302.
17. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM: A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012; 485:109-113.
18. Tsukiyama-Kohara K, Poulin F, Kohara M, DeMaria CT, Cheng A, Wu Z, Gingras AC, Katsume A, Elche-bly M, Spiegelman BM, Harper ME, Tremblay ML, Sonenberg N: Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nature 2001; 7:1128-1132.
19. Conn CS, Qian SB: Nutrient signaling in protein ho-meostasis: an increase in quantity at the expense of quality. Sci Signal 2013; 6:ra24.
20. Cho S, Hwang ES: Fluorescence-based detection and quantification of features of cellular senescence. Methods Cell Biol 2011; 103:149-188.
21. Rubinsztein DC, Mariño G, Kroemer G: Autophagy and aging. Cell 2011; 146:682-695.
22. Jia K, Levine B: Autophagy and longevity: lessons from C. elegans. Adv Exp Med Biol 2010; 694:47-60.
23. Nixon RA, Yang DS: Autophagy and neuronal cell death in neurological disorders. Cold Spring Harb Perspect Biol 2012; 4:pii a008839.
24. Lee HC, Wei YH: Mitochondria and aging. Adv Exp Med Biol 2012; 942:311-327.
25. Wouters BG, Koritzinsky M: Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 2008; 8:851-864.
26. Grimm C, Willmann G: Hypoxia in the eye: a two-sided coin. High Alt Med Biol 2012; 13:169-175.
27. Konisti S, Kiriakidis S, Paleolog EM: Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012; 8:153-162.
28. Ristow M, Zarse K: How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp Gerontol 2010; 45:410-418.
29. Polak P, Cybulski N, Feige JN, Auwerx J, Rüegg MA, Hall MN: Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008; 8:399-410.
30. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P: mTOR controls mito-chondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007; 450: 736-740.
31. Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT: Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010; 12:503-535.
32. Mattison JA, Roth GS, Beasley TM, Tilmont EM, Handy AM, Herbert RL, Longo DL, Allison DB, Young JE, Bryant M, Barnard D, Ward WF, Qi W, Ingram DK, de Cabo R: Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012; 489:318-321.
33. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325:201-204.
34. Dai DF, Chen T, Johnson SC, Szeto H, Rabinovitch PS: Cardiac aging: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 2012; 16:1492-1526.
35. Kim U, Park JS, Lee SH, Shin DG, Kim YJ: Seven-year clinical outcomes of sirolimus-eluting stent versus bare-metal stent: a matched analysis from a real world, single center registry. J Korean Med Sci 2013; 28:396-401.
36. Chong ZZ, Shang YC, Wang S, Maiese K: Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin. Prog Neurobiol 2012; 99:128-148.
37. Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, Austad SN, Strong R, Richardson A, Hart MJ, Galvan V: Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience 2012; 223:102-113.
38. Galanopoulou AS, Gorter JA, Cepeda C: Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia 2012; 53:1119-1130.
39. Ruiz-Falcó Rojas ML: Therapeutic update in tuberous sclerosis complex: the role of mTOR pathway inhibitors. Rev Neurol 2012; 54(suppl 3):S19-S24.
40. Laplante M, Sabatini DM: mTOR signaling in growth control and disease. Cell 2012; 149:274-293.
41. Laplante M, Sabatini DM: An emerging role of mTOR in lipid biosynthesis. Curr Biol 2009; 19:R1046-R1052.
42. Cybulski N, Polak P, Auwerx J, Rüegg MA, Hall MN: mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci USA 2009; 106:9902-9907.
43. Bell A, Grunder L, Sorisky A: Rapamycin inhibits human adipocyte differentiation in primary culture. Obes Res 2009; 8:249-254.
44. Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, Davis JG, Salmon AB, Richardson A, Ahima RS, Guertin DA, Sabatini DM, Baur JA: Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335:1638-1643.
45. Turner AP, Shaffer VO, Araki K, Martens C, Turner PL, Gangappa S, Ford ML, Ahmed R, Kirk AD, Lars-en CP: Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant 2011; 11:613-618.
46. Stahl A, Paschek L, Martin G, Gross NJ, Feltgen N, Hansen LL, Agostini HT: Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro. FEBS Lett 2008; 582:3097-3102.
47. Kolosova NG, Muraleva NA, Zhdankina AA, Ste-fanova NA, Fursova AZ, Blagosklonny MV: Prevention of age-related macular degeneration-like reti-nopathy by rapamycin in rats. Am J Pathol 2012; 181: 472-477.
48. Nussenblatt RB, Byrnes G, Sen HN, Yeh S, Faia L, Meyerle C, Wroblewski K, Li Z, Liu B, Chew E, Sherry PR, Friedman P, Gill F, Ferris F 3rd: A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization. Retina 2010; 30:1579-1587.
49. Graziotto JJ, Cao K, Collins FS, Krainc D: Rapamy-cin activates autophagy in Hutchinson-Gilford pro-geria syndrome: implications for normal aging and age-dependent neurodegenerative disorders. Au-tophagy 2012; 8:147-151.